Sign Up / Log In
Account
Online Pharmacy
Doctor Services
Health Centre
Bulk Purchase
Corporate
✕
Voucher Redeemed!
Voucher will be automatically applied upon checkout
*Limited to 1 use per customer only
*DOC reserves the right to reverse the voucher redemption and cancel any orders associated if the code is used more than once
Sold Out
Select Variant
Product Added to Your Cart
Jakavi 5mg Tablet 56s
RM 9105.40
You may take the Jakavi 5mg tablet with or without food. Also, in order to get the most effects it is to be taken at the same time daily. Your doctor can determine what dosage is required and how much you need to take. This depends on what you are being treated with and can vary from time to time. You must take it exactly as advised by the doctor. It may be risky to take it in the wrong way or taking too many.
Take this drug at the dosage regimen prescribed by your doctor. Swallow as a whole. Do not chew, crush or break the tablet. Fycompa 2mg Tablet can be taken with or without food, but it is best taken at a fixed time.
Tell the doctor if you have liver or renal issues when administering it or if you are using other antibiotics to cure illnesses. This medicine will interact by several different drugs, please let your doctor know all the medications you are using. During pregnancy or during breastfeeding, this medicine is not suggested. During treatment, use effective contraceptives between both men and women.
Few common side effects of this medication include headache, dizziness, low platelet count. This medicine can decrease the amount of blood cells in your blood, thereby increasing the susceptibility to infections. To check your blood cells along with heart, liver, kidney and lipid levels, routine blood testing is required
1. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1240.
2. Ruxolitinib. Greenville, North Carolina: DSM Pharmaceuticals, Inc.; 2011. [Accessed 24 Jan. 2019] (online) .
3. Wilmington, Delaware: Incyte Corporation; 2011 [revised Dec. 2014]. [Accessed 27 Mar. 2019] (online).